SECURITIES AND EXCHANGE COMMISSION
Washington, D. C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act
of 1934
Date of Report February 21, 1996
BARR LABORATORIES, INC.
(Exact name of registrant as specified in its charter)
New York 1-9860 22-1927534
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No.)
Two Quaker Road, P.O. Box 2900, Pomona, New York 10970-0519
(Address of principal executive offices) (Zip code)
(914) 362-1100
(Registrant's telephone number, including area code)
<PAGE>
BARR LABORATORIES, INC.
CURRENT REPORT dated February 21, 1996
Item 5. Other Events
See attached Exhibit 99.1, press release announcing the
declaration of a stock split.
Item 7. Financial Statements and Exhibits
(c) Exhibit Number Exhibit
99.1 Registrant's February 21, 1996 press
release announcing the declaration of a 3
for 2 stock split.
<PAGE>
BARR LABORATORIES, INC.
CURRENT REPORT dated February 21, 1996
SIGNATURES
Pursuant to the requirements of the Securities and Exchange
Act of 1934, the registrant has duly caused this report to be
signed on its behalf by the undersigned hereunto duly
authorized.
BARR LABORATORIES, INC.
Date: February 21, 1996 /S/ Paul M. Bisaro
Paul M. Bisaro
Vice President, Chief Financial Officer,
General Counsel and Corporate Secretary
[ARTICLE] 5
Exhibit 99.1
2 Quaker Road, P.O. Box 2900 N E W S R E L E A S E
Pomona, NY 10970
914-362-1100
CONTACT: Charles M. Mayr, 914-348-8050
Barr Laboratories Declares 3 for 2 Stock Split
Pomona, New York, February 21, 1996...Barr Laboratories, Inc.
(AMEX-BRL) today announced that its Board of Directors has
approved a 3 for 2 stock split effected in the form of a 50%
stock dividend. Approximately 4.7 million additional shares
of common stock will be distributed to shareholders of record
as of March 4, 1996. Fractional share amounts resulting from
the split will be paid to shareholders in cash. The Company
set the distribution date for March 25, 1996.
"The stock split reflects our optimism in the future prospects
of the Company," said Bruce L. Downey, Chairman, President and
Chief Executive Officer. "By splitting the stock, we reward
our shareholders with a broader stake in Barr's potential
success, while simultaneously lowering the stock price to a
range that should encourage additional investment by current
and potential shareholders. This action will increase the
overall number of shares available for trading, thereby
enhancing liquidity for the individual investor."
Barr Laboratories, Inc. is a leading independent developer,
manufacturer and marketer of high quality generic
pharmaceuticals.
[EDITOR'S ADVISORY: Barr Laboratories, Inc. news releases are
available free of charge through PR Newswire's News On-Call
fax service. For a menu of Barr's previous releases, or to
receive a specific release via fax call : 800-758-5804 --
ext. 089750, or use the Internet via
http://www.prnewswire.com/cnoc/exec/menu?089750.]
# # #
